LEADER 01749oam  2200421 a 450 
001 9910703191803321
005 20110504083633.0
035   $a(CKB)3460000000109354
035   $a(OCoLC)704281464
035   $a(EXLCZ)993460000000109354
100   $a20110228d2011      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFood and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases$b[electronic resource] $ehearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C
210  1$aWashington :$cU.S. G.P.O.,$d2011.
215   $a1 online resource (iii, 58 pages) $cillustrations
225 1 $aS. hrg. ;$v111-841
300   $aTitle from title screen (viewed on Feb. 28, 2011).
320   $aIncludes bibliographical references.
517   $aFood and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases 
606   $aRare diseases$xTreatment
606   $aTropical medicine
606   $aOrphan drugs$zUnited States
606   $aDrug development$xGovernment policy$zUnited States
615  0$aRare diseases$xTreatment.
615  0$aTropical medicine.
615  0$aOrphan drugs
615  0$aDrug development$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910703191803321
996   $aFood and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases$93464401
997   $aUNINA